Shiva Pharmachem Limited - Company Profile

Q: Who are the current directors of Shiva Pharmachem Limited?

The current directors of Shiva Pharmachem Limited are Jagmohan Manmohan Zalani, Taneja Premkumar, Rakesh Shivbhagwan Agrawal, Dukhabandhu Rath, Rahul Rakesh Agrawal, Rati Ajay Desai, Vishal Rakesh Agrawal, Milin Kaimas Mehta, Tarang Haresh Maru, Himali Harnish Patel.

It is a chemicals and materials public limited company based in Vadodara, Gujarat, India, established in 1999.

1999 Vadodara, Gujarat, India Active

Last Updated: December 17, 2025

Access Report

About Shiva Pharmachem Limited

Shiva Pharmachem Limited, a active public limited company, was established on 18 March 1999 in Vadodara, Gujarat, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U24231GJ1999PLC035615. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹28.00 Cr and a paid-up capital of ₹21.24 Cr.

Formerly known as Shiva Pharmachem Limited, Sppl India Limited. It upholds a compliant status. Employing 782 professional, Its leadership includes Jagmohan Manmohan Zalani (Whole-Time Director), Taneja Premkumar (Director), Rakesh Shivbhagwan Agrawal (Director). Past directors included Ravishankar Balakoteswararao Kompalli, Naina Krishna Murthy, Purushottam Dinkarrao Dhumal. It holds ₹769.70 Cr open charges and ₹273.15 Cr settled loans. Its latest AGM occurred on 14 September 2024, with the balance sheet filed on 31 March 2024. It is based at 12Th Floor, Shiva, Sarabhai Complex, Dr. Vikram Sarabhai Marg, Vadiwadi, Vadodara, Gujarat, 390023.

Company Details

CIN/LLPIN
U24231GJ1999PLC035615
Registration Number
035615
Incorporation Date
18 March 1999
Authorized Capital
₹28.00 Cr
Paid-Up Capital
₹21.24 Cr
ROC Code
Roc Ahmedabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 28.00 Cr as on 17-12-2025
Paid Up Capital ₹ 21.24 Cr as on 17-12-2025
Company Age 26 Year, 11 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 769.70 Cr as on 17-12-2025
Satisfied Charges ₹ 273.15 Cr as on 17-12-2025
Revenue Growth **** 7.40% (FY 2023)
Profit Growth **** 19.28% (FY 2023)
Ebitda **** 18.19% (FY 2023)
Net Worth 24.43% (FY 2023)
Total Assets **** 13.17% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Shiva Pharmachem Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Shiva Pharmachem Limited?

Current Directors

Name	Designation	Appointment Date	Status
Jagmohan Manmohan Zalani	Whole-Time Director	01 Apr 2015	Current
Taneja Premkumar	Director	30 Mar 2022	Current
Rakesh Shivbhagwan Agrawal	Director	29 Sep 2001	Current
Dukhabandhu Rath	Director	01 Oct 2022	Current
Rahul Rakesh Agrawal	Director	04 Sep 2015	Current
Rati Ajay Desai	Director	01 Mar 2023	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Whole-Time Director	30 Sep 2018	Past
Pramod Abcsdd	Additional Director	12 Nov 2022	Past
Pramod Abcsdd	Director	17 Feb 2022	Past
Pramod Abcsdd	Director	24 Mar 2022	Past
Pramod Abcsdd	Additional Director	12 Nov 2022	Past
Pramod Abcsdd	Director	18 Feb 2019	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Shiva Pharmachem.

Shiva Pharmachem Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.4% increase. The company also saw a substantial improvement in profitability, with a 19.28% increase in profit. The company's net worth Soared by an impressive increase of 24.43%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

7.40%

*******

Revenue from Operations

*******

7.49%

*******

Total Assets

*******

13.17%

*******

Profit or Loss

*******

19.28%

*******

Net Worth

*******

24.43%

*******

EBITDA

*******

18.19%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Shiva Pharmachem?

In 2023, Shiva Pharmachem had a promoter holding of 70.36% and a public holding of 29.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹7,696,953,200.00

Satisfied Charges

₹2,731,450,950.00

Charges Breakdown by Lending Institutions

Idbi Bank Limited : 365.00 Cr
Hdfc Bank Limited : 171.60 Cr
Others : 101.10 Cr
State Bank Of India : 82.00 Cr
Citi Bank N.A. : 50.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
08 Jan 2025	Hdfc Bank Limited	₹6.00 M	Open
15 Nov 2024	Hdfc Bank Limited	₹60.00 Cr	Open
25 Sep 2024	Others	₹1.10 Cr	Open
11 Jan 2024	State Bank Of India	₹82.00 Cr	Open
22 Nov 2023	Others	₹50.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Shiva Pharmachem?

Shiva Pharmachem has a workforce of 782 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Shiva Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shiva Pharmachem's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Shiva Pharmachem

Recent Activity within the Organization

Director Appointment

Progress on Himali Harnish Patel was appointed as a Cfo was appointed as a Cfo on 01 Oct 2025 & has been associated with this company since 4 months 25 days . was documented.
01 Oct 2025
Charges

Progress on A charge registered on 19 May 2011 via Charge ID 10291377 with Standard Chartered Bank was fully satisfied on 29 Sep 2025. was documented.
29 Sep 2025
Charges

Progress on A charge with Hdfc Bank Limited of Rs. 60.00 Cr registered on 15 Nov 2024 with Charge ID 101007827 was modified on 04 Apr 2025. was documented.
04 Apr 2025
Director Appointment

Milin Kaimas Mehta was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2025 & has been associated with this company since 10 months 24 days . was recorded as a recent event.
01 Apr 2025
Charges

The activity A charge with Hdfc Bank Limited amounted to Rs. 0.60 Cr with Charge ID 101027844 was registered on 08 Jan 2025. was completed.
08 Jan 2025
Charges

The activity A charge with Hdfc Bank Limited amounted to Rs. 60.00 Cr with Charge ID 101007827 was registered on 15 Nov 2024. was completed.
15 Nov 2024

Explore recent activity and updates - View Recent Activity